Synchron
synchron.com
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Synchron builds an endovascular brain-computer interface that is implanted through a blood vessel rather than open surgery. Founded in 2012 with Australian origins and now headquartered in New York, it has run clinical trials in both countries. Its decoding software lets paralysed users control digital devices with thought.
News
Apple has teamed up with Synchron to develop tech that lets people control its devices with thoughts
Apple has partnered with brain-computer interface maker Synchron. The two companies are developing tech that lets consumers operate Apple devices via their thoughts.
Read more
Report
Apple ventures into brain-computer interfaces, teams up with Synchron - WSJ
Investing.com -- Apple (NASDAQ:AAPL) is stepping into the realm of brain-computer interfaces (BCIs), a move that could potentially change the way we interact with our devices. The tech giant is collaborating with Synchron, a pioneer in the field, to devel
Read more
Report
Pro access
Upgrade to see all 31 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.